Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04936997 · ClinicalTrials.gov registry record · Early Phase 1
Immune Response to the COVID-19 Vaccine
A Early Phase 1 study, sponsored by University of Arizona.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 20
- Enrollment target
NCT04936997 is a Early Phase 1 study that has completed, run by University of Arizona. The registered enrollment target is 20 participants.
The verdict
NCT04936997, a Early Phase 1 study, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
Explore the effects on immune response to include a potential third vaccine for the cancer cohort.
Interventions
- BIOLOGICAL SARS-COV2 Pfizer Vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-06-07 |
| Est. Completion | 2022-05-08 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04936997
The ClinicalTrials.gov registry entry for NCT04936997 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SARS-COV2 Pfizer Vaccine is the first listed.
NCT04936997 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04936997 about?
NCT04936997 is a clinical study titled "Immune Response to the COVID-19 Vaccine". Explore the effects on immune response to include a potential third vaccine for the cancer cohort.
What is the current status of trial NCT04936997?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 20 participants. The study started on 2021-06-07. Estimated completion is 2022-05-08.
What interventions are being tested in trial NCT04936997?
The interventions under investigation include: SARS-COV2 Pfizer Vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT04936997?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.